Appropriately aggregate holistic technologies via accurate expertise. Intrinsicly strategize worldwide initiatives and premium methodologies.
Chemical and biological characterization of vaccine adjuvant QS-21 produced via plant cell culture
Journal article
Lv X. et al, (2024), iScience, 27
A Genome-Wide Association Study of Respiratory Syncytial Virus Infection Severity in Infants
Journal article
Johnson M. et al, (2024), The Journal of Infectious Diseases, 229, S112 - S119
Burden of Respiratory Syncytial Virus-Associated Acute Respiratory Infections During Pregnancy.
Journal article
Kenmoe S. et al, (2024), The Journal of infectious diseases, 229, S51 - S60
Estimating the subnational prevalence of antimicrobial resistant Salmonella enterica serovars Typhi and Paratyphi A infections in 75 endemic countries, 1990–2019: a modelling study
Journal article
Browne AJ. et al, (2024), The Lancet Global Health, 12, e406 - e418
Respiratory Syncytial Virus European Laboratory Network 2022 Survey: Need for Harmonization and Enhanced Molecular Surveillance.
Conference paper
Presser LD. et al, (2024), The Journal of infectious diseases, 229, S34 - S39
Targeted metagenomics reveals association between severity and pathogen co-detection in infants with respiratory syncytial virus.
Journal article
Lin G-L. et al, (2024), Nature communications, 15
Validity of Clinical Severity Scores for Respiratory Syncytial Virus: A Systematic Review.
Journal article
Sheikh Z. et al, (2024), The Journal of infectious diseases, 229, S8 - S17
Long-Term Clinical Safety of the Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: A Prospective, Multi-Country, Observational Study
Journal article
Puri A. et al, (2024), Vaccines, 12, 210 - 210
Demonstrating the utility of the ex vivo murine mycobacterial growth inhibition assay (MGIA) for high-throughput screening of tuberculosis vaccine candidates against multiple Mycobacterium tuberculosis complex strains
Journal article
Painter H. et al, (2024), Tuberculosis, 102494 - 102494
Fourth Controlled Human Infection Model (CHIM) meeting – CHIMs in endemic countries, May 22–23, 2023
Journal article
Kapulu M. et al, (2024), Biologicals, 101747 - 101747
Immune responses to typhoid conjugate vaccine in a two dose schedule among Nepalese children <2 years of age.
Journal article
Bijukchhe SM. et al, (2024), Vaccine
Revaccination with BCG: does it work?
Journal article
McShane H., (2024), The Lancet. Infectious diseases
Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial.
Journal article
Datoo MS. et al, (2024), Lancet (London, England), 403, 533 - 544
The burden of bacterial antimicrobial resistance in the WHO African region in 2019: a cross-country systematic analysis.
Journal article
Antimicrobial Resistance Collaborators None., (2024), The Lancet. Global health, 12, e201 - e216
The public health impact and cost-effectiveness of the R21/Matrix-M malaria vaccine: a mathematical modelling study.
Journal article
Schmit N. et al, (2024), The Lancet. Infectious diseases
MARS an improved de novo peptide candidate selection method for non-canonical antigen target discovery in cancer.
Journal article
Liao H. et al, (2024), Nat Commun, 15
Altered DNA methylation within DNMT3A, AHRR, LTA/TNF loci mediates the effect of smoking on inflammatory bowel disease
Journal article
Zhang H. et al, (2024), Nature Communications, 15
Apoptosis-mediated ADAM10 activation removes a mucin barrier promoting T cell efferocytosis
Journal article
Drexhage LZ. et al, (2024), Nature Communications, 15